Skip to main content
IN THE KNOW

Resources. Client news.

TOPICS

Client news
FDA approves first and only treatment for common mutation in advanced breast cancer.
The FDA approved a new drug that is a potential game changer for advanced breast cancer patients. Piqray (alpelisib) gained approval on May 24 for treatment of postmenopausal women and men with one of the most commonly mutated genes in advanced or metastatic breast cancer.
READ MORE
Client news
Dispelling the myth: generics are not always low cost.
When we hear the terms “generic” or “off-brand,” we typically think that the product would be a significantly cheaper alternative than the name brand. Well, when it comes to generic drugs, that’s not always in the case. Here are five facts plan sponsors should know:
READ MORE
Client news
National prescription drug take back day helps fight drug abuse.
+5,400 tons. That’s how much the DEA has collected of expired, unwanted or unused prescription medications over the past nine years through the National Prescription Drug Take Back Day program.
READ MORE
Client news
Paying for cures.
MedImpact sponsors MIT initiative to help make high-cost curative therapies more accessible
READ MORE
Client news
Combating the opioid crisis together.
MedImpact helps reduce opioid utilization in one of America's most affected states
READ MORE
Client news
MedImpact activates natural disaster response in wake of Hurricane Michael.
As Hurricane Michael — the strongest hurricane in history to hit the Florida Panhandle — continues to surge through the Southeast with damaging winds and flood-causing rains, MedImpact is committed to providing natural disaster support to our clients and members.
READ MORE
Client news
FDA approves new preventive treatment for rare hereditary disease.
The U.S. Food and Drug Administration (FDA) recently approved Takhzyro (lanadelumab-flyo) as the first preventive monoclonal antibody to treat hereditary angioedema (HAE) to help prevent attacks in patients 12 years and older. HAE is a rare and potentially life-threatening genetic disease that can cause unpredictable, debilitating episodes of painful swelling in the limbs, abdomen and airway.
READ MORE
Client news
Moving toward performance-based networks.
MedImpact discusses trends in value-based pharmacy reimbursement in Chain Drugstore Daily
READ MORE
We are the PBM that puts clients and consumers first. Always. Ready for a change?